Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer
Tianze Wang, Boyuan Nan, Qila Sa, Ning Xu, Wei Zhang, Shuyu Li · 2026
Read Lipid Metabolism–Related Genes Define Prognosis and Therapeutic Targets in Thyroid Cancer by Tianze Wang, Boyuan Nan, Qila Sa, Ning Xu, Wei Zhang, Shuyu Li (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13181148.txt.
Description
Tianze Wang, Boyuan Nan, and Qila Sa lead a team linking fat metabolism genes to thyroid cancer's course and nominating one gene as a working part of the disease. Their study appeared in two thousand twenty-six. Tumors rewire lipid handling to grow, but thyroid cancer's version of that story was unwritten. The team attacked it from genetics, tissue data, and single cells at once.
Inherited evidence tied lipid metabolites causally to the cancer. A nine-gene signature split patients into risk groups with strong accuracy. High-risk tumors showed hotter lipid pathways, a distinct immune mix, and more key mutations. Silencing one signature gene slowed cancer cells' growth, invasion, and movement in dishes. That gene becomes a candidate target. The signature itself could refine who needs aggressive treatment. Lipid routes, the authors argue, deserve a place in thyroid oncology.
Catalog record
| CREATOR | Tianze Wang, Boyuan Nan, Qila Sa, Ning Xu, Wei Zhang, Shuyu Li |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 60 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |